Anti-LYVE1 antibody (ab33682) is a rabbit polyclonal antibody detecting LYVE1 in IHC-P, ICC/IF. Suitable for Mouse.
- Over 40 publications
- Trusted since 2007
View Alternative Names
CRSBP1, HAR, XLKD1, UNQ230/PRO263, LYVE1, Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1, Cell surface retention sequence-binding protein 1, Extracellular link domain-containing protein 1, Hyaluronic acid receptor, CRSBP-1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody (AB33682)
IHC image of LYVE1 staining in a section of formalin-fixed paraffin-embedded normal mouse large intestine performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 minutes. The section was then incubated with ab33682, 1 μg/mL, for 15 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Reactivity data
Product details
Anti-LYVE1 antibody (ab33682) has been cited over 47 times in peer reviewed journals and is trusted by the scientific community.
Abcam's high quality validation processes ensure Anti-LYVE1 antibody (ab33682) has high sensitivity and specificity.
Anti-LYVE1 antibody (ab33682) has 12 independent reviews from customers.
Anti-LYVE1 antibody (ab33682) specifically detects LYVE1 (UniProt ID: Q9Y5Y7; Molecular weight: 33kDa) and is sold in 100 µg selling sizes.
LYVE-1 (Lymphatic Vessel Endothelial Receptor 1) is primarily expressed on lymphatic endothelial cells and plays a crucial role in hyaluronan (HA) transport and turnover. It is also involved in lymphangiogenesis and immune responses, with altered LYVE-1 expression linked to various diseases, including cancer and inflammatory conditions. For instance, LYVE-1 expression is downregulated in human liver cancer and cirrhosis. Additionally, it is linked to intramuscular hemangioma and complete androgen insensitivity syndrome. Changes in LYVE-1 expression can impact lymphangiogenesis and immune responses, contributing to disease progression.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LYVE1 plays a role in lymphatic system regulation and immune cell trafficking. It forms part of a network that binds hyaluronan contributing to the regulation of cell migration and adhesion. This protein interacts with molecules like CD44 and other receptors which also participate in hyaluronan binding. LYVE1's function in maintaining the balance of hyaluronan within tissues is central affecting not only the lymphatic system but also immune responses.
Pathways
LYVE1 engages in both the hyaluronan metabolism and lymphangiogenesis pathways. Its interaction with CD44 plays a significant role in the transport and uptake of hyaluronan influencing cellular processes such as proliferation and motility. These interactions link LYVE1 to pathways controlling fluid balance and immune surveillance marking it as essential for maintaining healthy lymphatic and immune function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (62)
Recent publications for all applications. Explore the full list and refine your search
The Journal of experimental medicine 222: PubMed40970910
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature cardiovascular research 4:1221-1240 PubMed40954306
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4021 PubMed40301362
2025
Applications
Unspecified application
Species
Unspecified reactive species
Gels (Basel, Switzerland) 10: PubMed39590104
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 25:2270-2283 PubMed39587345
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 13:e70273 PubMed39382373
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 36:2383-2401.e9 PubMed39270655
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0308273 PubMed39088551
2024
Applications
Unspecified application
Species
Unspecified reactive species
The journal of pathology. Clinical research 10:e12388 PubMed38923836
2024
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive medicine and biology 23:e12570 PubMed38566911
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com